Nova vacina contra câncer de pele reduz em 49% risco de morte e retorno do tumor

A vacina personalizada, com o imunoterápico Keytruda, mostrou em testes clínicos resultados promissores no combate ao melanoma

Jornal da USP
Moderna mRNA-4157 (V90) news for head and neck cancer patients like me

The best treatment candidate for keeping me alive that I’m aware of is Moderna’s mRNA-4157 personalized cancer vaccine: in very early data from 2020, a 10-person dosing study found that the treatme…

The Story's Story